D+ synthesis pathways
D+ synthesis pathways. In the De novo biosynthetic pathway, tryptophan is converted to quinolinic acid in 6 steps of enzymatic reactions, which is then converted to nicotinic acid mononucleotide (NAMN) by the enzyme quinolinate phosphoribosyltransferase (QPRT). The Preiss-Handler pathway is initiated by NA phosphoribosyltransferase (NAPRT) to form NAMN. NAMN is further converted to NA adenine dinucleotide (NAAD) by NMN adenylyl transferase enzymes (NMNAT1-3). Finally, NAAD is converted to NAD+ via an amidation reaction catalyzed by the enzyme NAD+ synthase (NADSYN). The Core Recycling and Salvage Pathways are the shortest pathways for NAD+ synthesis from NAM and NR (2 steps). NAM is converted to NMN by the rate-limiting nicotinamide phosphoribosyl transferase (NAMPT). NMN is also a product of NR phosphorylation by NR kinases (NRK1-2). The subsequent conversion of NMN to NAD+ is catalyzed by NMNAT1-3 enzymes. Further, the synthesized NAD+ is used in the functioning of NAD+-dependent enzymes (SIRTs, PARPs). As a result of their reaction (deacetylation, poly-ADP-ribosylation, respectively), NAM is formed again, which later turns into NMN using the intracellular form of NAM-phosphoribosyltransferase. NA, nicotinic acid; NAAD, NA adenine dinucleotide; NADSYN, NAD+ synthetase; NAM, nicotinamide; NAMN, NA mononucleotide; NMN, NAM mononucleotide; NMNAT, NMN adenylyltransferase; NR, nicotinamide riboside; NRK, NR kinase.
Publication
The Role of NAD+, SIRTs Interactions in Stimulating and Counteracting Carcinogenesis (2023) Ekaterina Podyacheva, et al. Int J Mol Sci. 2023 May;24(9). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | NAPRT | NAPRT | ncbigene_symbol | NAPRT | 93100 |
| Homo sapiens | Primates | OPRT | OPRT | ncbigene_synonym | UMPS | 7372 |
| Homo sapiens | Primates | 0-p-0 | OPO | ncbigene_synonym | OFCC1 | 266553 |
| Homo sapiens | Primates | NMNAT1-3 | NMNAT3 | ncbigene_symbol | NMNAT3 | 349565 |
| Homo sapiens | Primates | NMNAT1-3 | NMNAT1 | ncbigene_symbol | NMNAT1 | 64802 |
| Homo sapiens | Primates | NMNAT1-3 | NMNAT2 | ncbigene_symbol | NMNAT2 | 23057 |
| Homo sapiens | Primates | NAMPT | NAMPT | ncbigene_symbol | NAMPT | 10135 |
| Homo sapiens | Primates | (NAM) | NAM | ncbigene_synonym | STAC3 | 246329 |
| Homo sapiens | Primates | NRK1-2 | NRK2 | ncbigene_synonym | NEK4 | 6787 |
| Homo sapiens | Primates | NRK1-2 | NRK2 | ncbigene_synonym | NMRK2 | 27231 |
| Homo sapiens | Primates | NRK1-2 | NRK1 | ncbigene_synonym | NMRK1 | 54981 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| L-Tryptophan | L-tryptophan | (2S)-2-azaniumyl-3-(1H-indol-3-yl)propanoate | chebi:57912 | |
| Nicotinic acid | nicotinic acid | pyridine-3-carboxylic acid | chebi:15940 | |
| Quinolinic acid | QUINOLINIC ACID | pyridine-2,3-dicarboxylic acid | chebi:16675 | |
| NMN | NMN | 3-carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridinium | chebi:16171 | |
| NAMPT | Nampt | chebi:195368 | ||
| Nicotinamide | nicotinamide | nicotinamide | chebi:17154 | |
| Nicotinamide riboside | Nicotinamide riboside | beta-nicotinamide D-riboside | chebi:15927 | |
| PARPS | PARPs | chebi:62913 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|